Contracting COVID-19 is nearly as effective at preventing reinfection as the two top coronavirus vaccines — but there are a few catches.
A study by Public Health England, which has yet to be peer reviewed, tested 21,000 health-care workers across the U.K. and found 6,614 of them had antibodies against COVID-19, indicating they'd contracted the virus in the past. But of those who'd been infected, 44 had possibly gotten the virus again despite their antibodies, indicating an 83 percent chance of protection against reinfection over five months, CNN reports.
As Forbes notes, 83 percent isn't far off from the 95 percent effectiveness provided by Moderna's vaccine, or the 94 percent from Pfizer's. Still, that percentage means it's very possible for people who've gotten the virus to contract it again, the study notes. That fact has been proven over the past year as people who've recovered from COVID-19 have tested positive for it again months later. Researchers also found those who were seemingly immune to the virus may still carry it around and transmit it to other people, showing why it's still important to wear a mask and take other precautions regardless of past infections or vaccination.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The study will keep monitoring the workers for a year to determine just how long the antibody protections last.
-
Israel: Losing the American publicFeature A recent poll finds American support for Israel's military action in Gaza has fallen from 50% to 32%
-
Unmaking AmericansFeature Trump is threatening to revoke the citizenship of foreign-born Americans. Could he do that?
-
EPA: A bonfire of climate change regulationsFeature The Environmental Protection Agency wants to roll back its 'endangerment finding,' a ruling that lets the agency regulate carbon emissions
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive orderspeed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
